Cargando…

Nogo-Receptor 1 Deficiency Has No Influence on Immune Cell Repertoire or Function during Experimental Autoimmune Encephalomyelitis

The potential role of Nogo-66 Receptor 1 (NgR1) on immune cell phenotypes and their activation during neuroinflammatory diseases such as multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), is unclear. To further understand the function of this receptor on h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Litwak, Sara A., Payne, Natalie L., Campanale, Naomi, Ozturk, Ezgi, Lee, Jae Young, Petratos, Steven, Siatskas, Christopher, Bakhuraysah, Maha, Bernard, Claude C. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855334/ https://www.ncbi.nlm.nih.gov/pubmed/24339996 http://dx.doi.org/10.1371/journal.pone.0082101

Ejemplares similares

Nogo receptor expression in microglia/macrophages during experimental autoimmune encephalomyelitis progression
por: Alrehaili, Amani A., et al.
Publicado: (2018)

Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?
por: Bakhuraysah, Maha M., et al.
Publicado: (2016)

Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis
por: McDonald, Courtney A., et al.
Publicado: (2015)

How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis?
por: Rashidbenam, Zahra, et al.
Publicado: (2023)

Nogo receptor-Fc delivered by haematopoietic cells enhances neurorepair in a multiple sclerosis model
por: Ye, Sining, et al.
Publicado: (2023)

Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis
por: Nheu, Danica, et al.
Publicado: (2022)

Nogo-A antibody delivery through the olfactory mucosa mitigates experimental autoimmune encephalomyelitis in the mouse CNS
por: Pernet, Vincent, et al.
Publicado: (2023)

The Beta-Amyloid Protein of Alzheimer's Disease: Communication Breakdown by Modifying the Neuronal Cytoskeleton
por: Mokhtar, Sara H., et al.
Publicado: (2013)

Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?
por: Kim, Min Joung, et al.
Publicado: (2018)

Mgat5 Deficiency in T Cells and Experimental Autoimmune Encephalomyelitis
por: Grigorian, Ani, et al.
Publicado: (2011)

Progranulin deficiency confers resistance to autoimmune encephalomyelitis in mice
por: Schmitz, Katja, et al.
Publicado: (2019)

That’s a Wrap! Molecular Drivers Governing Neuronal Nogo Receptor-Dependent Myelin Plasticity and Integrity
por: Petratos, Steven, et al.
Publicado: (2020)

Nogo-Receptors NgR1 and NgR2 Do Not Mediate Regulation of CD4 T Helper Responses and CNS Repair in Experimental Autoimmune Encephalomyelitis
por: Steinbach, Karin, et al.
Publicado: (2011)

Effects of Bu Shen Yi sui capsule on NogoA/NgR and its signaling pathways RhoA/ROCK in mice with experimental autoimmune encephalomyelitis
por: Fang, Ling, et al.
Publicado: (2017)

B-cells expressing NgR1 and NgR3 are localized to EAE-induced inflammatory infiltrates and are stimulated by BAFF
por: Bakhuraysah, Maha M., et al.
Publicado: (2021)

Nogo receptor 1 regulates Caspr distribution at axo-glial units in the central nervous system
por: Lee, Jae Young, et al.
Publicado: (2017)

Experimental Autoimmune Encephalomyelitis Induction in Genetically B Cell–deficient Mice
por: Wolf, Susan D., et al.
Publicado: (1996)

Delayed Onset of Experimental Autoimmune Encephalomyelitis in Olig1 Deficient Mice
por: Guo, Xiaoli, et al.
Publicado: (2010)

RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis
por: Lee, Jae-Kyung, et al.
Publicado: (2016)

Nogo-A and Nogo-66 receptor in amyotrophic lateral sclerosis
por: Teng, Felicia Yu Hsuan, et al.
Publicado: (2008)

Antibody repertoire and autoimmunity
por: Skevaki, Chrysanthi, et al.
Publicado: (2023)

The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis
por: Dahl, Lisa CM, et al.
Publicado: (2016)

P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis
por: Sharp, Anthony J, et al.
Publicado: (2008)

NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis
por: Reppert, Sarah, et al.
Publicado: (2015)

Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis
por: Bozoyan, Lusine, et al.
Publicado: (2015)

Cytosolic phospholipase A(2)α–deficient mice are resistant to experimental autoimmune encephalomyelitis
por: Marusic, Suzana, et al.
Publicado: (2005)

Partial Deficiency of Sphingosine-1-Phosphate Lyase Confers Protection in Experimental Autoimmune Encephalomyelitis
por: Billich, Andreas, et al.
Publicado: (2013)

Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
por: Paris, Daniel, et al.
Publicado: (2013)

Environmental Influences in Experimental Autoimmune Encephalomyelitis
por: Constantinescu, Cris S
Publicado: (2005)

Experience-dependent expression of Nogo-A and Nogo receptor in the developing rat visual cortex
por: Wu, Xiaoying, et al.
Publicado: (2012)

Exacerbation of experimental autoimmune encephalomyelitis in mice deficient for DCIR, an inhibitory C-type lectin receptor
por: SENO, Akimasa, et al.
Publicado: (2014)

Protoporphyrin Treatment Modulates Susceptibility to Experimental Autoimmune Encephalomyelitis in miR-155-Deficient Mice
por: Zhang, Jinyu, et al.
Publicado: (2015)

Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination
por: Theotokis, Paschalis, et al.
Publicado: (2016)

Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs
por: Yang, Yuhong, et al.
Publicado: (2010)

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Girolamo, Francesco, et al.
Publicado: (2014)

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
por: Basler, Michael, et al.
Publicado: (2014)

Contribution of Pannexin1 to Experimental Autoimmune Encephalomyelitis
por: Lutz, Sarah E., et al.
Publicado: (2013)

The Role of ERK Signaling in Experimental Autoimmune Encephalomyelitis
por: Birkner, Katharina, et al.
Publicado: (2017)

Amelioration of experimental autoimmune encephalomyelitis by Ishige okamurae
por: Ahn, Meejung, et al.
Publicado: (2018)

Oryeongsan (Goreisan) Ameliorates Experimental Autoimmune Encephalomyelitis
por: Inada, Rino, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_36etdebju86eb3pecspq0ui8bk